Please use this identifier to cite or link to this item: https://doi.org/10.1136/jclinpath-2012-201140
Title: Immunohistochemistry in the era of personalised medicine
Authors: McCourt, C.M.
Boyle, D.
James, J.
Salto-Tellez, M. 
Issue Date: Jan-2013
Citation: McCourt, C.M., Boyle, D., James, J., Salto-Tellez, M. (2013-01). Immunohistochemistry in the era of personalised medicine. Journal of Clinical Pathology 66 (1) : 58-61. ScholarBank@NUS Repository. https://doi.org/10.1136/jclinpath-2012-201140
Abstract: Background: Immunohistochemistry (IHC) plays a central role in the histopathological classification of diseases, including cancer. More recently, the importance of immunohistochemical staining is increasing. IHC usage in diagnostics is invaluable; however, the genetic and therapeutic significance of biomarker immunostaining has become equally relevant. Content: In this article, we would like to analyse the three distinct roles of IHC and review their individual impacts on modern diagnostic pathology: (1) diagnostic IHC; (2) genetic IHC and (3) therapeutic IHC. Summary: Thus, we will characterise the different analytical processes that are required in the three approaches to IHC usage stated above, as well as the clinical significance and overall importance in patient management. This will allow us to hypothesise on the most appropriate laboratory environment and detection methods for the future.
Source Title: Journal of Clinical Pathology
URI: http://scholarbank.nus.edu.sg/handle/10635/110749
ISSN: 00219746
DOI: 10.1136/jclinpath-2012-201140
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

30
checked on Oct 12, 2021

WEB OF SCIENCETM
Citations

28
checked on Oct 12, 2021

Page view(s)

84
checked on Oct 14, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.